I now have excellent source material. Let me craft the case.
Clinical Case: "The Shaky Professor"
Patient Presentation
Mr. R.K., 62-year-old male, retired university physics professor, presents to a neurology outpatient clinic accompanied by his daughter.
Chief complaint: "My handwriting has gotten terrible over the past two years, and I keep dropping my coffee mug."
History of Presenting Illness
The patient reports a two-year progressive course of fine motor deterioration. He initially attributed his tremulous handwriting to "too many years at a chalkboard." His daughter, who arranged the appointment, notes he has become increasingly forgetful about recent events - he will recount a conversation from 1987 in perfect detail but cannot remember what he ate for breakfast.
He was seen by his GP 18 months ago for dizziness and unsteadiness on stairs, diagnosed as benign positional vertigo and managed with Epley manoeuvres with no sustained improvement. Six months later he visited an orthopaedic surgeon for bilateral knee pain and a feeling of heaviness in his legs, attributed to osteoarthritis - X-rays were unremarkable.
Most recently he visited a cardiologist for palpitations and intermittent lightheadedness on standing, diagnosed with dysautonomia and managed conservatively. An echocardiogram revealed mild aortic root dilation (4.1 cm), noted but not further investigated, attributed to his age and decades of borderline hypertension.
He takes ramipril 5 mg OD and atorvastatin 20 mg OD. No family history is offered by the patient.
Systems Review (as reported by patient)
- Neurological: Intermittent tingling and numbness in both feet, worse at night ("probably diabetic neuropathy - my sugar was borderline once"). No frank weakness volunteered.
- Psychiatric: "A bit more anxious than usual." Sleep has worsened. He finds social situations "tiring," preferring to avoid faculty gatherings he previously enjoyed.
- Gastrointestinal: Constipation, worsening over 12 months.
- Musculoskeletal: Joint laxity noted since youth ("I was always very flexible"), never investigated.
Family History (elicited only after targeted questioning)
- A sister, aged 57, stopped menstruating at age 36 ("the doctors said early menopause, she never had a full workup").
- A nephew (sister's son), aged 29, attends a special school; described by family as "slow since childhood, always hyperactive." No formal diagnosis given to the family.
- A maternal uncle, deceased at 71, had "Parkinson's disease" - never confirmed with genetic or specialist workup.
Examination Findings
| System | Finding |
|---|
| Gait | Wide-based, mildly ataxic; tandem gait impossible |
| Upper limb | Bilateral intention tremor on finger-nose test; more prominent on the right |
| Lower limb | Reduced proprioception bilaterally; absent ankle reflexes |
| Cognition | MMSE 24/30; loses points on delayed recall and serial 7s |
| Face | Mildly elongated facies, large and somewhat prominent ears - features present since youth, never commented on by physicians |
| Genitalia | Macroorchidism - not examined (patient refused) |
| Cardiovascular | BP 148/88 mmHg sitting, drops to 122/74 on standing (orthostatic drop); mild aortic root dilatation on echo |
Investigations Ordered (and their misleading results)
| Investigation | Result | Misleading Interpretation |
|---|
| MRI Brain | White matter T2/FLAIR hyperintensities in the middle cerebellar peduncles (MCP sign) | Reported as "likely small vessel ischaemic change" by a general radiologist unfamiliar with the MCP sign |
| Nerve conduction studies | Sensorimotor peripheral neuropathy, axonal pattern | Attributed to statin use; statin dose reduced |
| Thyroid function | TSH mildly elevated (4.9 mU/L) | Levothyroxine added, tremor attributed to hypothyroidism |
| HbA1c | 43 mmol/mol (borderline) | Peripheral neuropathy attributed to pre-diabetes |
| Dopamine transporter scan (DaT-SPECT) | Normal | "Rules out Parkinson's disease" - falsely reassuring, since FXTAS-associated parkinsonism may show normal DaT scans |
| Chromosome microarray (ordered later) | Not ordered initially | --- |
The Diagnostic Trap
The case is designed to mislead in several directions simultaneously:
Red herrings placed at every turn:
- Age + hypertension + white matter changes = automatically triggers the "small vessel disease" pathway. The MCP sign - pathognomonic for FXTAS - is missed because the radiologist does not recognize it.
- Tremor + gait instability + mild cognition decline in a 62-year-old male = the obvious call is idiopathic Parkinson's disease or essential tremor. The normal DaT scan would typically be interpreted as reassuring.
- Peripheral neuropathy + borderline HbA1c + statin use = a cluster of three plausible alternative explanations, each individually convincing.
- Autonomic dysfunction (orthostatic hypotension, constipation) = attributed to age and antihypertensive medication.
- Aortic root dilation = known systemic feature of FXS/FXPAC, but in a 62-year-old hypertensive male it is invisible against the clinical background noise.
- The family history is the key - but it is scattered across three relatives and requires active synthesis: a sister with premature ovarian insufficiency (POI) before age 40, a nephew with likely undiagnosed FXS, and a "Parkinsonian" maternal uncle - this is the classic FXTAS pedigree pattern. However, the patient volunteered none of this and it required systematic targeted questioning to uncover.
What Is Actually Happening
This is Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) in a male premutation carrier (estimated CGG repeat range 55-200) of the FMR1 gene.
The patient does not have Fragile X Syndrome itself (which would require >200 repeats with full methylation and FMRP silencing). He carries a premutation allele. The mechanism here is entirely different: rather than loss of FMRP protein, the premutation produces excess FMR1 mRNA that accumulates in intranuclear inclusions in neurons and astrocytes, triggering neurodegeneration via RNA gain-of-function toxicity (repeat-associated non-AUG translation, RAN translation, and mRNA aggregation).
The nephew with intellectual disability and the classic male phenotype is the full-mutation individual - the true "Fragile X case" in the family - through whom this premutation pedigree is traced. The patient himself never presented with intellectual disability, macrocephaly, or autism; he has had a full academic career.
Secondary/indirect findings that should trigger suspicion (none of them classic FXS):
- Progressive intention tremor beginning in the sixth decade
- Cerebellar ataxia (wide-based gait, tandem failure)
- Short-term memory loss with preserved remote memory (executive-frontal pattern)
- Peripheral neuropathy (axonal, distal, lower limb predominant)
- Autonomic neuropathy (orthostatic hypotension, constipation)
- Proximal lower limb muscle weakness (subtle, missed on routine examination)
- Anxiety and mood symptoms (FXPAC-associated neuropsychiatric features)
- Aortic root dilation (systemic connective tissue feature of FMR1-related conditions)
- MCP sign on MRI (white matter hyperintensities in middle cerebellar peduncles)
- Family history of premature ovarian insufficiency in a female relative
- Family member with intellectual disability consistent with full FXS
Confirmatory Workup
FMR1 CGG repeat PCR + Southern blot analysis of peripheral blood DNA.
Expected result: premutation allele with ~90-160 CGG repeats (premutation range), without hypermethylation of the FMR1 promoter, and with elevated FMR1 mRNA on quantitative PCR.
Genetic counselling should be offered to all family members. The sister should be offered testing for her own premutation status and referred for reproductive endocrinology follow-up for her POI. The nephew should undergo formal FXS testing.
Why This Case Is Difficult
The patient never displays a single direct feature of Fragile X syndrome: no intellectual disability, no autism, no macroorchidism on voluntary examination, no childhood developmental delay, no characteristic facial gestalt in its full form. Every finding has a more common, age-appropriate alternative explanation. The diagnosis requires:
- Recognising that a premutation carrier is not protected - they develop a distinct and mechanistically separate late-onset neurodegenerative syndrome
- Knowing the MCP sign and its specificity for FXTAS
- Knowing that normal DaT-SPECT does not exclude FXTAS-parkinsonism
- Actively constructing a three-generation pedigree and recognising that scattered, seemingly unrelated diagnoses (early menopause, childhood intellectual disability, late-life parkinsonism) represent a single X-linked premutation lineage
- Knowing that aortic root dilation is a systemic feature associated with FMR1-related conditions, not just Marfan syndrome
- Resisting the pull of five competing, individually plausible diagnoses
Sources: Thompson & Thompson Genetics and Genomics in Medicine (9th ed.); Creasy & Resnik's Maternal-Fetal Medicine; Bradley & Daroff's Neurology in Clinical Practice; ACMG FMR1 Standards and Guidelines; Frontiers in Pediatrics - FXPAC review (2020)